Sensus Healthcare, Inc. (SRTS) Misses Q1 EPS by 25c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Sensus Healthcare Reports First Quarter 2023 Financial Results
May 3, 2023 4:05 PM EDTLower demand for SRT systems reflects the impact of inflation on dermatologists cash flow from fewer elective aesthetic procedures and higher operating costs
Sensus expects to ship more than 60 SRT units during 2023 and return to profitability in the second half of the year
Conference call begins at 4:30 p.m. Eastern time today
BOCA RATON, Fla., May 03, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and... More
